Common drug tested to cut opioid use after back surgery
NCT ID NCT06513208
Summary
This study is testing whether giving the anti-inflammatory drug ketorolac after spinal fusion surgery can safely reduce patients' pain and their need for opioid painkillers. Researchers will compare ketorolac to a placebo in 140 adults having one or two levels of their lower back fused. The main goals are to see if it lowers opioid use and hospital stay without harming the success of the spinal fusion.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUMBAR SPINAL FUSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Maryland St. Joseph Medical Center
RECRUITINGTowson, Maryland, 21204, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.